Infographic: Perceptions of Treatments in AML – A Survey of 375 European Haematologists - European Medical Journal

Infographic: Perceptions of Treatments in AML – A Survey of 375 European Haematologists

Hematology
Download PDF

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Acute myeloid leukaemia (AML) is a rapidly progressing haematological cancer with a poor prognosis. This infographic summarises the key results from an online survey conducted in 2022 on the perceptions of AML treatments among clinicians in Europe. Haematologists and oncologists from five European countries were asked their opinions on topics such as first-line treatments, the intensity of treatment regimens, and therapies for curative intent for patients with AML.

This Infographic was developed and funded by Jazz Pharmaceuticals and is intended for European Healthcare Professionals only.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now